Advanced company searchLink opens in new window

DASHTAG

Company number 00090627

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
07 Jun 2024 AD01 Registered office address changed from The Hewett Building 14 Hewett Street London EC2A 3NP United Kingdom to Organon Pharma (Uk) Limited Shotton Lane Cramlington England and Wales NE23 3JU on 7 June 2024
20 Apr 2024 RESOLUTIONS Resolutions
  • RES13 ‐ Reducing share premium account 10/04/2024
22 Mar 2024 AP01 Appointment of Isabel Vandenberk as a director on 1 March 2024
22 Mar 2024 TM01 Termination of appointment of Torben Dahl as a director on 29 February 2024
22 Mar 2024 AP01 Appointment of Ms Sandy Lindsey as a director on 1 March 2024
22 Mar 2024 AP01 Appointment of Mr Michael Whale as a director on 1 March 2024
21 Mar 2024 TM01 Termination of appointment of Simon Khalid Hussain as a director on 29 February 2024
21 Mar 2024 TM01 Termination of appointment of Simon Nicholson as a director on 15 February 2024
21 Mar 2024 AP01 Appointment of Mr Josef Ralph Laskowski as a director on 1 March 2024
14 Dec 2023 CS01 Confirmation statement made on 14 December 2023 with no updates
05 Oct 2023 AA Full accounts made up to 31 December 2022
14 Dec 2022 CS01 Confirmation statement made on 14 December 2022 with no updates
13 Sep 2022 AA Full accounts made up to 31 December 2021
21 Dec 2021 CS01 Confirmation statement made on 14 December 2021 with updates
20 Dec 2021 RP04AP01 Second filing for the appointment of Torben Dahl as a director
20 Sep 2021 AP01 Appointment of Dahl Torben as a director on 28 May 2021
  • ANNOTATION Clarification a second filed AP01 was registered 20/12/2021.
20 Sep 2021 AP01 Appointment of Simon Khalid Hussain as a director on 28 May 2021
02 Sep 2021 AA Full accounts made up to 31 December 2020
16 Jun 2021 PSC02 Notification of Organon & Co., Inc. as a person with significant control on 2 June 2021
16 Jun 2021 PSC07 Cessation of Merck & Co., Inc. as a person with significant control on 2 June 2021
16 Jun 2021 PSC02 Notification of Merck & Co., Inc. as a person with significant control on 1 March 2021
16 Jun 2021 PSC07 Cessation of Schering-Plough Holdings Limited as a person with significant control on 1 March 2021
10 Jun 2021 TM01 Termination of appointment of Ebru Can Temucin as a director on 28 May 2021
08 Jun 2021 TM01 Termination of appointment of David Peacock as a director on 28 May 2021
07 Jun 2021 AP03 Appointment of John Albert Parsons as a secretary on 28 May 2021